CLDN4 and hepatocellular carcinoma: Thirdly, tumor heterogeneity and microenvironment adaptation: heterogeneity in ADH1C deficiency or spatial distribution of CLDN4+ cells in HCC contributes to variable treatment responses (226, 229).